Evidence map›Paper›PMID 36264758›Full record

ArticleAnnals of clinical and translational neurology2022

Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking.

Federico Carbone, Laura Zamarian, Verena Rass, Stefanie Bair, Marcel Ritter, Ronny Beer, Philipp Mahlknecht, Beatrice Heim, Victoria Limmert, Marina Peball and 12 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Objective and subjective cognitive outcomes one year after COVID-19.Annals of clinical and translational neurology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Federico CarboneDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0002-6909-0150
Laura Zamarian *Department of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Verena Rass *Department of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Stefanie BairDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Marcel RitterInteractive Graphics and Simulation Group, University of Innsbruck, 6020, Innsbruck, Austria.
Ronny BeerDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Philipp MahlknechtDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Beatrice HeimDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0002-6749-3044
Victoria LimmertDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Marina PeballDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0002-0791-7300
Philipp EllmererDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0001-7043-2309
Alois Josef SchiefeckerDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Mario KoflerDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Anna LindnerDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Bettina PfauslerDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Lauma PutninaDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Philipp KindlDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Judith Löffler-RaggDepartment of Internal Medicine II, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Stefan KiechlDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Klaus SeppiDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Atbin DjamshidianDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0001-7174-6000
Raimund HelbokDepartment of Neurology, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Innsbruck Medical University · ATUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments. Individuals who recovered from COVID-19 made significantly more errors in all eye tracking tasks compared to age/sex-matched healthy controls. Furthermore, patients who were treated as inpatients performed worse compared to outpatients and controls. Our results show impaired inhibitory cortical control in individuals who recovered from COVID-19. The association between disease severity and its sequelae may contribute to a better understanding of post-COVID-19 cognitive function.

Indexed as

Cognition DisordersCognitive DysfunctionCOVID-19Cross-Sectional StudiesEye-Tracking TechnologyHumans

Identifiers

PMID36264758
PMCPMC9639623
OpenAlexW4306893332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.